137 related articles for article (PubMed ID: 20093186)
1. In vitro characterization and pharmacokinetics in mice following pulmonary delivery of itraconazole as cyclodextrin solubilized solution.
Yang W; Chow KT; Lang B; Wiederhold NP; Johnston KP; Williams RO
Eur J Pharm Sci; 2010 Mar; 39(5):336-47. PubMed ID: 20093186
[TBL] [Abstract][Full Text] [Related]
2. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.
Yang W; Tam J; Miller DA; Zhou J; McConville JT; Johnston KP; Williams RO
Int J Pharm; 2008 Sep; 361(1-2):177-88. PubMed ID: 18556158
[TBL] [Abstract][Full Text] [Related]
3. Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats.
Yang W; Johnston KP; Williams RO
Eur J Pharm Biopharm; 2010 May; 75(1):33-41. PubMed ID: 20102737
[TBL] [Abstract][Full Text] [Related]
4. Single dose and multiple dose studies of itraconazole nanoparticles.
Vaughn JM; McConville JT; Burgess D; Peters JI; Johnston KP; Talbert RL; Williams RO
Eur J Pharm Biopharm; 2006 Jun; 63(2):95-102. PubMed ID: 16516450
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of novel itraconazole-loaded intravenous nanoparticles.
Chen W; Gu B; Wang H; Pan J; Lu W; Hou H
Int J Pharm; 2008 Oct; 362(1-2):133-40. PubMed ID: 18585448
[TBL] [Abstract][Full Text] [Related]
6. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention.
Duret C; Merlos R; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Eur J Pharm Biopharm; 2014 Jan; 86(1):46-54. PubMed ID: 23523546
[TBL] [Abstract][Full Text] [Related]
8. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
9. Preparation of itraconazole-loaded liposomes coated by carboxymethyl chitosan and its pharmacokinetics and tissue distribution.
Wang J; Huang G
Drug Deliv; 2011 Nov; 18(8):631-8. PubMed ID: 22111976
[TBL] [Abstract][Full Text] [Related]
10. Studies on itraconazole delivery and pharmacokinetics in mallard ducks (Anas platyrhynchos).
Tell LA; Craigmill AL; Clemons KV; Sun Y; Laizure SC; Clifford A; Ina JH; Nugent-Deal JP; Woods L; Stevens DA
J Vet Pharmacol Ther; 2005 Jun; 28(3):267-74. PubMed ID: 15953200
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and biodistribution of itraconazole in rats and mice following intravenous administration in a novel liposome formulation.
Tang J; Wei H; Liu H; Ji H; Dong D; Zhu D; Wu L
Drug Deliv; 2010 May; 17(4):223-30. PubMed ID: 20210560
[TBL] [Abstract][Full Text] [Related]
12. Cryogenic liquids, nanoparticles, and microencapsulation.
Purvis T; Vaughn JM; Rogers TL; Chen X; Overhoff KA; Sinswat P; Hu J; McConville JT; Johnston KP; Williams RO
Int J Pharm; 2006 Oct; 324(1):43-50. PubMed ID: 16814968
[TBL] [Abstract][Full Text] [Related]
13. Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model.
McConville JT; Overhoff KA; Sinswat P; Vaughn JM; Frei BL; Burgess DS; Talbert RL; Peters JI; Johnston KP; Williams RO
Pharm Res; 2006 May; 23(5):901-11. PubMed ID: 16715380
[TBL] [Abstract][Full Text] [Related]
14. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
[TBL] [Abstract][Full Text] [Related]
15. Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles.
Chen W; Zhan C; Gu B; Meng Q; Wang H; Lu W; Hou H
J Drug Target; 2011 Apr; 19(3):228-34. PubMed ID: 20540685
[TBL] [Abstract][Full Text] [Related]
16. Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole.
DiNunzio JC; Miller DA; Yang W; McGinity JW; Williams RO
Mol Pharm; 2008; 5(6):968-80. PubMed ID: 19434851
[TBL] [Abstract][Full Text] [Related]
17. Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model.
Alomrani AH; Shazly GA; Amara AA; Badran MM
Colloids Surf B Biointerfaces; 2014 Sep; 121():74-81. PubMed ID: 24937135
[TBL] [Abstract][Full Text] [Related]
18. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
19. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs.
Ungaro F; De Rosa G; Miro A; Quaglia F; La Rotonda MI
Eur J Pharm Sci; 2006 Aug; 28(5):423-32. PubMed ID: 16806857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
